These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29678478)

  • 21. CD271 Down-Regulation Promotes Melanoma Progression and Invasion in Three-Dimensional Models and in Zebrafish.
    Saltari A; Truzzi F; Quadri M; Lotti R; Palazzo E; Grisendi G; Tiso N; Marconi A; Pincelli C
    J Invest Dermatol; 2016 Oct; 136(10):2049-2058. PubMed ID: 27328305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia-Inducible Factor-1α and CD271 inversely correlate with melanoma invasiveness.
    Marconi A; Borroni RG; Truzzi F; Longo C; Pistoni F; Pellacani G; Pincelli C
    Exp Dermatol; 2015 May; 24(5):396-8. PubMed ID: 25739328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cell marker CD271 is expressed by vasculogenic mimicry-forming uveal melanoma cells in three-dimensional cultures.
    Valyi-Nagy K; Kormos B; Ali M; Shukla D; Valyi-Nagy T
    Mol Vis; 2012; 18():588-92. PubMed ID: 22419851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD271 determines migratory properties of melanoma cells.
    Radke J; Roßner F; Redmer T
    Sci Rep; 2017 Aug; 7(1):9834. PubMed ID: 28852061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cuprous oxide nanoparticle-inhibited melanoma progress by targeting melanoma stem cells.
    Yu B; Wang Y; Yu X; Zhang H; Zhu J; Wang C; Chen F; Liu C; Wang J; Zhu H
    Int J Nanomedicine; 2017; 12():2553-2567. PubMed ID: 28435246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. low neurotrophin receptor CD271 regulates phenotype switching in melanoma.
    Restivo G; Diener J; Cheng PF; Kiowski G; Bonalli M; Biedermann T; Reichmann E; Levesque MP; Dummer R; Sommer L
    Nat Commun; 2017 Dec; 8(1):1988. PubMed ID: 29215016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humanized anti-CD271 monoclonal antibody exerts an anti-tumor effect by depleting cancer stem cells.
    Morita S; Mochizuki M; Wada K; Shibuya R; Nakamura M; Yamaguchi K; Yamazaki T; Imai T; Asada Y; Matsuura K; Sugamura K; Katori Y; Satoh K; Tamai K
    Cancer Lett; 2019 Oct; 461():144-152. PubMed ID: 31325530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ki-67, Bcl-2 and p53 expression in primary and metastatic melanoma.
    Ilmonen S; Hernberg M; Pyrhönen S; Tarkkanen J; Asko-Seljavaara S
    Melanoma Res; 2005 Oct; 15(5):375-81. PubMed ID: 16179864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enriching and characterizing cancer stem cell sub-populations in the WM115 melanoma cell line.
    Chandrasekaran S; DeLouise LA
    Biomaterials; 2011 Dec; 32(35):9316-27. PubMed ID: 21917310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defective autophagy leads to the suppression of stem-like features of CD271
    Zhang D; Zhao Q; Sun H; Yin L; Wu J; Xu J; He T; Yang C; Liang C
    J Biomed Sci; 2016 Nov; 23(1):82. PubMed ID: 27863492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical significance of serum NGF level and CD271 expression in patients with acute B lymphoid leukemia].
    Han XH; Xu KL; Zeng LY; Li ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1273-6. PubMed ID: 22040987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and prognostic value of putative cancer stem cell markers CD117 and CD15 in choroidal and ciliary body melanoma.
    Lukenda A; Dotlic S; Vukojevic N; Saric B; Vranic S; Zarkovic K
    J Clin Pathol; 2016 Mar; 69(3):234-9. PubMed ID: 26290260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
    Fröhlich E; Mack AF; Garbe C; Klessen C
    Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Putative Cancer Stem Cell Markers are Frequently Expressed by Melanoma Cells
    Speigl L; Janssen N; Weide B; Sinnberg T; Pawelec G; Shipp C
    Front Biosci (Landmark Ed); 2023 Sep; 28(9):193. PubMed ID: 37796710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mixed versus pure variants of desmoplastic melanoma: a genetic and immunohistochemical appraisal.
    Miller DD; Emley A; Yang S; Richards JE; Lee JE; Deng A; Hoang MP; Mahalingam M
    Mod Pathol; 2012 Apr; 25(4):505-15. PubMed ID: 22157936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-related decrease in CD271(+) cells in human skin.
    Akamatsu H; Hasegawa S; Yamada T; Mizutani H; Nakata S; Yagami A; Matsunaga K
    J Dermatol; 2016 Mar; 43(3):311-3. PubMed ID: 26300383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do DLX3 and CD271 Protect Human Keratinocytes from Squamous Tumor Development?
    Palazzo E; Marconi A; Pincelli C; Morasso MI
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31331058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD271 on melanoma cell is an IFN-γ-inducible immunosuppressive factor that mediates downregulation of melanoma antigens.
    Furuta J; Inozume T; Harada K; Shimada S
    J Invest Dermatol; 2014 May; 134(5):1369-1377. PubMed ID: 24226422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic superiority for cartilage repair by CD271-positive marrow stromal cell transplantation.
    Mifune Y; Matsumoto T; Murasawa S; Kawamoto A; Kuroda R; Shoji T; Kuroda T; Fukui T; Kawakami Y; Kurosaka M; Asahara T
    Cell Transplant; 2013; 22(7):1201-11. PubMed ID: 23044363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.